LAUSR

variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. Lancet Respir Med 2013;1: 309–317. 6. Han MK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, et al.; COMET Investigators. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Lancet Respir Med 2014;2:548–556. 7. Dickson RP, Huffnagle GB, Flaherty KR, White ES, Martinez FJ, Erb-Downward JR, et al. Radiographic honeycombing and altered lung microbiota in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2019;200: 1544–1547. 8. Sulaiman I, Wu BG, Li Y, Tsay JC, Sauthoff M, Scott AS, et al. Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism. Eur Respir J 2021;58: 2003434. 9. Li X, Kim SE, Chen TY, Wang J, Yang X, Tabib T, et al. Toll interacting protein protects bronchial epithelial cells from bleomycin-induced apoptosis. FASEB J 2020;34:9884–9898. 10. Huang Y, Ma SF, Espindola MS, Vij R, Oldham JM, Huffnagle GB, et al.; COMET-IPF Investigators. Microbes are associated with host innate immune response in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2017;196:208–219. 11. Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, et al. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2000;2:346–351.